Moody Aldrich Partners LLC Amarin Corp Plcuk Transaction History
Moody Aldrich Partners LLC
- $475 Million
- Q4 2024
Shares
2 transactions
Others Institutions Holding AMRN
# of Institutions
183Shares Held
71.2MCall Options Held
183KPut Options Held
66.7K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$10.9 Million3.7% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.4MShares$5.46 Million0.38% of portfolio
-
Morgan Stanley New York, NY4.41MShares$1.94 Million0.0% of portfolio
-
Scp Investment, LP2.5MShares$1.1 Million1.0% of portfolio
-
Waterfront Wealth Inc.2.48MShares$1.09 Million0.31% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $177M
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...